3D Bioprinting for Tissue Engineering and Regenerative Medicine
A special issue of Bioengineering (ISSN 2306-5354).
Deadline for manuscript submissions: closed (18 June 2021) | Viewed by 14717
Special Issue Editor
Interests: tissue and organ printing; tissue engineering; regenerative medicine; biomaterials; organ-on-a-chip; translation; regulation and standardization
Special Issue Information
Dear Colleagues,
The emergence of 3D bioprinting technology in tissue engineering and regenerative medicine has shown great promise in recent years that represents a significant advancement in reverse engineering artificial tissues and organs. This state-of-the-art technology involves the layer-by-layer positioning of living human cells and growth factors with biomaterials (i.e., bioinks) for fabricating complex functional tissues and organs. This versatile technology has already shown enormous progress for the generation and transplantation of miniaturized tissues and creating 3D in vitro models for drug discovery and screening applications. However, there are still many technical and translational challenges that need to be addressed. These include the development of biocompatible bioinks, the vascularization of tissues, and the resolution of 3D bioprinters, among others. This Special Issue will cover recent and innovative advances in the 3D bioprinting of tissues and organs, including methodologies, bioink development, applications, technical and translational challenges, regulatory pathways and standardization, and future developments.
Assist. Prof. Houman Savoji
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Bioengineering is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- 3D bioprinting
- Tissue and organ printing
- Tissue engineering
- Regenerative medicine
- Bioinks
- Stem cells
- Vascularization
- Structure–function
- Translation
- Regulation and standardization
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
